Antiarrhythmic Drug Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy

Antiarrhythmic Drug Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heritable progressive myocardial disorder that predisposes patients to ventricular arrhythmias and sudden cardiac death. Antiarrhythmic medications have an important role in reducing the frequency of ventricular arrhythmias and the morbidit...

Full description

Bibliographic Details
Main Authors: Sean P. Gaine, Hugh Calkins
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Biomedicines
Subjects:
ARVC
antiarrhythmic
arrhythmia
flecainide
amiodarone
sotalol
Online Access:https://www.mdpi.com/2227-9059/11/4/1213

Internet

https://www.mdpi.com/2227-9059/11/4/1213

Similar Items